Skip to main content
. 2013 Aug 21;13:392. doi: 10.1186/1471-2407-13-392

Figure 2.

Figure 2

Overall survival of patients based on IGF1R and IGFBP3 expression. The survival curve shows the Kaplan-Meier overall survival curves in relation to the IGF1R and IGFBP3 levels in patients with pancreatic cancer. A statistically significant difference in survival was observed between patients with IGF1R-positive and IGF1R-negative tumors (p = 0.018). The prognosis of patients with IGF1R-positive and IGFBP3-negative patients showed a significant correlation with overall survival (p < 0.001). IGFBP3 expression alone tended to be associated with overall survival (p = 0.079). The co-expression of IGF1R-negative and IGFBP3-positive PDAC was not associated with overall survival (p = 0.218).